Background: Despite their specific functional hazards, radiotherapy induced thyroid disorders remain underevaluated, even though, various types of irradiation caused either benign and malignant changes of the thyroid gland have been mentioned in this study. Aim: To report the current status concerning the hazards of various types of irradiation on the detection of different thyroid abnormalities either benign and/or malignant changes.
Introduction
The thyroid gland has two sided lobes linked by a central lobe called isthmus which is positioned at the lower neck.
The thyroid gland secretes and stores thyroid hormones that are necessary in regulating growth, metabolism, reproduction and other physiological processes [1] . Thyroid gland considers one of the organs mostly produce clinically/subclinically abnormalities after therapeutic external radiation [2] . Radiation hazards induced thyroid abnormalities were first registered in thyrotoxic patients administered radiotherapy in 1920s [3] . Later, radioactive iodine (RAI) was used in patients with cardiac diseases to decrease their metabolic rate (BMR) [4, 5] . The initial reports on hypothyroidism after receiving radiotherapy on neck region were detected since 1960s, [6, 7] . About 20-30% of patients with lymphomas, and head and neck cancers (HNCs) affected by RT-induced thyroid disturbances, after receiving curative radiotherapy to the neck region and with approximately half of these events occurring within the first 5 years after treatment [8] [9] [10] . The thyroid gland receives a significant dose of radiation Gy) after RT to head and neck region as the whole gland or large part of it is cited in or around the target organ which leads to abnormal hypothyroidism, Graves'disease, and hyperparathyroidism [11] . Repeated curative or accidental radiation of the thyroid gland raises the incidence of thyroid tumors. Two-thirds of benign tumors occurring after external beam irradiation, and the other one third are malignant, mostly well-differentiated, and rarely advanced cancers (90% are papillary type) [12] . These tumors do not differ clinically from accidentally occurring thyroid cancers [13, 14] . They are often followed or associated with benign adenomas. The risk of secondary thyroid malignancy increases up to 15-to 53-fold versus non-irradiated population [15] . In this study, we summarize the current status concerning the hazards of different types of irradiation on the development of benign, malignant structural and functional diseases of the thyroid. Through a retrospective analysis on 40 cancer patients with different primaries treated with different doses of radiotherapy in which clinical assessment and anatomical imaging tools were performed for clinical evaluation of the thyroid gland associated with histopathological examinations for suspected malignancies in the thyroid gland.
Eligibility: After taking the Ethical Review
Committee approval and informed consent from each patient before participation in the study, only 40 cancer patients met the following eligibility criteria were selected carefully: (1) Histologically proven primary cancer with no other evidence of distant metastases at the thyroid gland (2) who were euthyroid clinically(with normal hormonal profiles) preceding irradiation to the neck region. Patients with a past history of any thyroid problems or on any thyroid therapy were excluded. Normal TFT, were defined as; (TSH) ≤4. 2 mIU/L; (FT4) 12.5-22 pmol/L and (T3) between 3.1 and 5.5 pmol/L. The clinical target volume, both lungs and the heart, but not the thyroid gland were routinely delineated in the planning CT images. The breast/chest wall should receive a total dose of 60/50 Gy, and the regional lymph nodes 46-50 Gy, using photon energy 6-15 Mev on linac. Median absorbed dose in the thyroid gland after breast cancer irradiation is 30 Gy.
Radiation therapy

For breast cancer:
For lymphomas:
The extent of radiation therapy ranged from treatment one or more of the involved fields included the thyroid region. The radiation doses were depended using either 2DRTH or 3DRTH with the protection of midline structures using either lead blocks or MLC but inevitable considerable dose (ranging from 35Gy to 40Gy) to the thyroid occurred.
For naso/hypopharynx and MUO with cervical
lymph nodes: patients were treated with 3DRTH over 2 Gy daily fractions. Most patients were treated at 2Gy per fraction for 33-35 fractions (according to stage and bulky lymph node existence). Elective nodal regions in the neck were generally treated to 46-54 Gy. Because planning objectives to reduce the thyroid dose were not used for most patients, many patients received large, unavoidable radiation doses to the thyroid, with significant portions of the gland receiving ≤50 Gy. Median absorbed dose in the thyroid gland after head & neck irradiation is 42Gy. 
Thyroid function assessment:
Statistical analysis
SPSS version for windows version
Results
After 
Patients gender
65% of the patients were females with 46.1% of them showed multinodular goiter with normal thyroid function on thyroid U.S, there is no statistical difference between male and female in the occurrence of benign and malignant structural thyroid diseases (P-value>0.05).
Patients age
Patients are divided into two groups according to their ages (cut off age=56ys), older patients with papillary cancer thyroid showed a significant difference as compared to the younger group (P-value=0.004), while the other benign structural thyroid diseases showed no significance between the both groups.
Primary tumor pathology
The evidence of benign and malignant structural changes in the thyroid gland showed no statistical significance among the patients with different primaries (P-value>0.05).
Radiation doses (Gy)
Patients who received less than 50 Gy of the radiotherapy showed a significant increase in the incidence of multinodularity in the thyroid gland, while the patients who received more than 50Gy, the incidence of malignant thyroid diseases (papillary or follicular type) was significantly high.
Post-therapy follow up(m/ys)
The incidence of nodular goiter of the thyroid gland in cancer patients showed a significant increase over follow up time as well as in patients with papillary cancer thyroid (P-value<0.05). 
Gender
Discussion
Numerous thyroid disorders may develop after irradiation to the low neck, using fields that include all or part of the [23] .
In this study, we analyzed different risk factors such as sex, age, primary tumor location, radiation dose and follow up duration. Diaz et al, reported that the gland with small volume had a high incidence for development of post-RT thyroid hazards [24] . Furthermore, Alterio et al. verified that women's thyroid glands were less influenced by radiation hazards as they have smaller volume than men's [9] . We found that female sex was associated with a high incidence of thyroid disorders (26/44) compared with male sex (14/40) with no significant correlation among them in the development of post-RT benign and malignant structural thyroid changes (P-value>0.05). However, when we grouped the patients according to age above and below 56 years, we found that older age was a significant risk factor for post-RT malignant changes (P-value=0.004). The increased efficacy of RT in elder patients who have a decline in sodium iodine symporter activity or maybe there is something intrinsic to either the cancer or the treatment may explain the greater incidence of malignancy in this group (≥56years) [25] . However, the effect of age has been disproved by many researchers [26] [27] [28] . The difference of our study from others could be that age was analyzed in two groups (<56ys and ≥56ys). naso/hypopharynx) could be significant, because it is located in very proximity to the target of irradiation [29] [30] . Conversely, some studies found no association between incidence of thyroid dysfunction and primary tumor site irradiation as in our study [9, 31, 32] . The significant effect of radiation dose on the risk of post-RT thyroid changes was also reported in some studies [27, [33] [34] , Our result show that if the mean radiation dose received by the thyroid was less than 50 Gy, it is a significant risk factor for post-RT nodular thyroid changes and this risk starts after 20 Gy (P-value=0.001). On the other hand, if the mean radiation dose received by the thyroid was more than 50Gy, it is a significant risk factor for post-RT malignant thyroid changes (P-value<0.05)
Conversely, with other literature [23, 27, 35, 36] . The time to development of thyroid changes had not been conclusively defined. Prospective trials have been conducted in an attempt to answer this question [37, 38] . In our study, The incidence of nodularity as well as malignant changes at the thyroid gland showed a significant increase over follow up time (P-value<0.05).
Conclusion
Numerous thyroid disorders may develop following irradiation to the thyroid gland. Patients age older than 56ys and high radiation dose (>50Gy) play an important role in the occurrence of structural thyroid changes. Therefore, thyroid functional imaging (Neck U/S, thyroid scan) should be checked on a regular basis every 6 months for the first 5 years after RT and annually thereafter in all patients who receive more than 50 Gy to the thyroid, regardless of clinical symptoms. Further prospective studies with large sample size are warranted in order to understand better the dose-effect and to reduce the incidence of radiotherapyinduced thyroid dysfunction.
